- Report
- November 2025
- 120 Pages
Europe
From €2955EUR$3,250USD£2,541GBP
- Report
- October 2025
- 60 Pages
United States
From €2319EUR$2,550USD£1,993GBP
- Report
- October 2025
- 100 Pages
United States
From €4092EUR$4,500USD£3,518GBP
- Report
- October 2025
- 89 Pages
United States
From €4092EUR$4,500USD£3,518GBP
- Report
- October 2025
- 84 Pages
Middle East
From €4092EUR$4,500USD£3,518GBP
- Report
- October 2025
- 93 Pages
Middle East
From €4092EUR$4,500USD£3,518GBP
- Report
- October 2025
- 83 Pages
Middle East
From €4092EUR$4,500USD£3,518GBP
- Report
- October 2025
- 86 Pages
Middle East
From €4092EUR$4,500USD£3,518GBP
- Report
- October 2025
- 88 Pages
Asia Pacific
From €4092EUR$4,500USD£3,518GBP
- Report
- October 2025
- 90 Pages
Middle East
From €4092EUR$4,500USD£3,518GBP
- Report
- October 2025
- 87 Pages
United States
From €4092EUR$4,500USD£3,518GBP
- Report
- October 2025
- 86 Pages
Middle East
From €4092EUR$4,500USD£3,518GBP
- Report
- October 2025
- 242 Pages
United States
From €1682EUR$1,850USD£1,446GBP
- Report
- October 2025
- 91 Pages
Middle East
From €4092EUR$4,500USD£3,518GBP
- Directory
- January 2026
- 80 Pages
Global
- Report
- July 2025
- 36 Pages
Global
- Report
- May 2024
- 344 Pages
Global
From €5237EUR$5,961USD£4,350GBP
- Report
- February 2024
- 280 Pages
Global
From €5237EUR$5,961USD£4,350GBP
- Report
- February 2024
- 322 Pages
Global
From €5237EUR$5,961USD£4,350GBP
- Report
- January 2024
- 348 Pages
Global
From €5237EUR$5,961USD£4,350GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more